[1] 邓璐, 何江涛, 邹华, 等. 洛美沙星对水中反硝化过程的影响模拟试验 [J]. 中国环境科学, 2020, 40(7): 2934-2942. doi: 10.3969/j.issn.1000-6923.2020.07.017 DENG L, HE J T, ZOU H, et al. Simulation experiments on effects of lomefloxacin on denitrification process in water [J]. China Environmental Science, 2020, 40(7): 2934-2942(in Chinese). doi: 10.3969/j.issn.1000-6923.2020.07.017
[2] 陈淋鹏, 黄福杨, 张冲, 等. 诺氟沙星对地下水中反硝化过程的影响: 反硝化酶活性的证据 [J]. 环境科学学报, 2020, 40(7): 2496-2501. CHEN L P, HUANG F Y, ZHANG C, et al. Effect of norfloxacin on denitrification process in groundwater: Evidence for denitrifying enzyme activity [J]. Acta Scientiae Circumstantiae, 2020, 40(7): 2496-2501(in Chinese).
[3] CHEN K, ZHOU J L. Occurrence and behavior of antibiotics in water and sediments from the Huangpu River, Shanghai, China [J]. Chemosphere, 2014, 95: 604-612. doi: 10.1016/j.chemosphere.2013.09.119
[4] LOOFT T, JOHNSON T A, ALLEN H K, et al. In-feed antibiotic effects on the swine intestinal microbiome [J]. Proceedings of the National Academy of Sciences of the United States of America, 2012, 109(5): 1691-1696. doi: 10.1073/pnas.1120238109
[5] YAN C X, YANG Y, ZHOU J L, et al. Antibiotics in the surface water of the Yangtze Estuary: Occurrence, distribution and risk assessment [J]. Environmental Pollution, 2013, 175: 22-29. doi: 10.1016/j.envpol.2012.12.008
[6] ZHAO H, ZHOU J L, ZHANG J. Tidal impact on the dynamic behavior of dissolved pharmaceuticals in the Yangtze Estuary, China [J]. Science of the Total Environment, 2015, 536: 946-954. doi: 10.1016/j.scitotenv.2015.06.055
[7] 倪语星, 王金良, 徐英春. 抗微生物药物敏感性试验规范[M]. 2版. 上海: 上海科学技术出版社, 2009: 18-37. NI Y X, WANG J L, XU Y C. Antimicrobial susceptibility testing good laboratory practices[M]. Shanghai: Shanghai Scientific & Technical Publishers, 2009: 18-37(in Chinese).
[8] 张玉叶, 何江涛, 张金刚, 等. 喹诺酮类典型抗生素对反硝化细菌的联合药敏试验研究 [J]. 环境科学学报, 2021, 41(2): 670-679. doi: 10.13671/j.hjkxxb.2020.0309 ZHANG Y Y, HE J T, ZHANG J G, et al. Combined susceptibility testing for denitrifying bacteria by typical quinolone antibiotics [J]. Acta Scientiae Circumstantiae, 2021, 41(2): 670-679(in Chinese). doi: 10.13671/j.hjkxxb.2020.0309
[9] Clinical and Laboratory Standards Institute. CLSI document M44-A. Method for antifungal disk diffusion susceptibility testing of yeasts; approved guideline. 2nd ed[S]. Wayne: Clinical and Laboratory Standards Institute; 2004.
[10] Clinical and Laboratory Standards Institute. CLSI document M27-A3: Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. 3rd ed[S]. Wayne: Clinical and Laboratory Standards Institute; 2008.
[11] Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]//TERTEL M L, CHRISTOPHER J P, PHUCAS A B(eds. ), Twenty-sixth informational supplement. CLSI document M100-S26. Wayne, PA, 2016: 52–59.
[12] National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi[S]. Approved standard. Document M38-A. National Committee for Clinical Laboratory Standards, Wayne, Pa, 2008.
[13] National Committee for Clinical Laboratory Standards. Reference method for broth dilution susceptibility testing of yeasts[S]. Approved Standard, 2nd ed. Document M27–A2. National Committee for Clinical Laboratory Standards, Wayne, Pa, 2002.
[14] PILLAI S K, MOELLERING R C, Jr, ELIOPOULOS GM. Antimicrobial combinations//LORIAN V (ed), Antibiotics in Laboratory Medicine, 6th ed[M]. Lippincott Williams & Wilkins Co. , Philadelphia, PA, 2015.
[15] LERER A L. Synergism testing: broth microdilution checkerboard and broth macrodilution methods[M]//Clinical Microbiology Procedures Handbook. Washington, DC, USA: ASM Press, 2016: 5.16. 1-5.16. 23.
[16] BONAPACE C R, BOSSO J A, FRIEDRICH L V, et al. Comparison of methods of interpretation of checkerboard synergy testing [J]. Diagnostic Microbiology and Infectious Disease, 2002, 44(4): 363-366. doi: 10.1016/S0732-8893(02)00473-X
[17] den HOLLANDER J G, MOUTON J W, VERBRUGH H A. Use of pharmacodynamic parameters to predict efficacy of combination therapy by using fractional inhibitory concentration kinetics [J]. Antimicrobial Agents and Chemotherapy, 1998, 42(4): 744-748. doi: 10.1128/AAC.42.4.744
[18] ELIOPOULOS G M. Synergism and antagonism [J]. Infectious Disease Clinics of North America, 1989, 3(3): 399-406. doi: 10.1016/S0891-5520(20)30277-4
[19] ANON. Synergism testing: broth microdilution checkerboard and broth macrodilution methods[M]//Clinical Microbiology Procedures Handbook. Washington, DC, USA: ASM Press, 2016: 5.16. 1-5.16. 23.
[20] MARYMONT J H Jr, MARYMONT J. Laboratory evaluation of antibiotic combinations: A review of methods and problems [J]. Laboratory Medicine, 1981, 12(1): 47-55. doi: 10.1093/labmed/12.1.47
[21] HUANG Y Q, ZHOU Q, WANG W G, et al. Acinetobacter baumannii ventilator-associated pneumonia: Clinical efficacy of combined antimicrobial therapy and in vitro drug sensitivity test results [J]. Frontiers in Pharmacology, 2019, 10: 92. doi: 10.3389/fphar.2019.00092
[22] 冯建科, 王立新, 秦蓓蓓, 等. 烧伤科患者感染铜绿假单胞菌外排泵基因变异及耐药性分析 [J]. 中国病原生物学杂志, 2015, 10(8): 754-758. doi: 10.13350/j.cjpb.150820 FENG J K, WANG L X, QIN B B, et al. Study of efflux pump genes of Pseudomonas aeruginosa infecting patients in burn wards and analysis of the drug resistance of P. aeruginosa [J]. Journal of Pathogen Biology, 2015, 10(8): 754-758(in Chinese). doi: 10.13350/j.cjpb.150820
[23] MATSUMURA S O, LOUIE L, LOUIE M, et al. Synergy testing of vancomycin-resistant Enterococcus faecium against quinupristin-dalfopristin in combination with other antimicrobial agents [J]. Antimicrobial Agents and Chemotherapy, 1999, 43(11): 2776-2779. doi: 10.1128/AAC.43.11.2776
[24] ZOU H, HE J T, HE B N, et al. Sensitivity assessment of denitrifying bacteria against typical antibiotics in groundwater [J]. Environmental Science. Processes & Impacts, 2019, 21(9): 1570-1579.